Study to Evaluate Dietary Supplementation With a Version of Anatabloc(R) in Subjects With Alzheimer's Disease (ASAP)

This study has suspended participant recruitment.
(Pending clarification of the administrative status of active ingredient anatabine)
Sponsor:
Collaborator:
Roskamp Institute Inc.
Information provided by (Responsible Party):
Rock Creek Pharmaceuticals, Inc.
ClinicalTrials.gov Identifier:
NCT01669876
First received: August 17, 2012
Last updated: March 5, 2014
Last verified: March 2014
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has suspended participant recruitment.
  Estimated Study Completion Date: February 2015
  Estimated Primary Completion Date: December 2014 (Final data collection date for primary outcome measure)